RY

Rahul Yashawantrao Wandile

Active Director Director DIN 11081292
DIN 11081292 First appointment Apr 2025 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Rahul Yashawantrao Wandile

Data last updated:

Rahul Yashawantrao Wandile is a Director at Tiwa Fertility Centre And Woman Care Hospital Private Limited (since 2025). The company operates in Healthcare.

DIN 11081292
Primary Designation Director
Industry Healthcare
First Appointment 29 Apr 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director29 Apr 20252025Active

Board colleagues of Rahul Yashawantrao Wandile

Directorship timeline

Open interactive timeline →
Tiwa Fertility Centre And Woman Care Hospital Private Limited
Premium access

Shareholding and investment profile for Rahul Yashawantrao Wandile

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rahul Yashawantrao Wandile

Rahul Yashawantrao Wandile currently holds 1 directorship: Tiwa Fertility Centre And Woman Care Hospital Private Limited (Director, since 29 Apr 2025).

Rahul Yashawantrao Wandile was first appointed on 29 Apr 2025 as Director at Tiwa Fertility Centre And Woman Care Hospital Private Limited.

The current boards of Rahul Yashawantrao Wandile's companies include Pallawi Motiramji Tipale (Tiwa Fertility Centre And Woman Care Hospital Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available